Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
The pneumococcal polysaccharide conjugate vaccine Prevenar 13® (PCV13) comprises 13 capsular
Streptococcus pneumoniae
polysaccharide serotypes that are individually conjugated to nontoxic diphtheria protein (cross-reactive material [CRM
197
]).
In randomized, comparator-controlled, phase III trials in healthy infants aged 2–6 months,...
Alternative Titles
Full title
Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_907166950
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_907166950
Other Identifiers
ISSN
0012-6667
E-ISSN
1179-1950
DOI
10.2165/11205110-000000000-00000
